Literature DB >> 24236805

Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast.

Patrick L Fitzgibbons1, Deborah A Dillon, Randa Alsabeh, Michael A Berman, Daniel F Hayes, David G Hicks, Kevin S Hughes, Sharon Nofech-Mozes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24236805     DOI： 10.5858/arpa.2013-0566-CP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  27 in total

1.  Digital image analysis outperforms manual biomarker assessment in breast cancer.

Authors:  Gustav Stålhammar; Nelson Fuentes Martinez; Michael Lippert; Nicholas P Tobin; Ida Mølholm; Lorand Kis; Gustaf Rosin; Mattias Rantalainen; Lars Pedersen; Jonas Bergh; Michael Grunkin; Johan Hartman
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

2.  The Relationship between Bone Mineral Density and Estrogen Receptor Positivity in Patients with Breast Cancer.

Authors:  Zeynep Erdoğan İyigün; Kezban Nur Pilancı; Fatmagül Kuşku Çabuk; Serkan İlgün; Çetin Ordu; Tomris Duymaz; Gül Alço; Filiz Çelebi; Dauren Sarsenov; Filiz İzci; Alper Öztürk; Filiz Ağaçayak; Ülkühan İner Köksal; Fatma Aktepe; Yeşim Eralp; Vahit Özmen
Journal:  J Breast Health       Date:  2016-07-01

Review 3.  Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review.

Authors:  Nickolay Fedchenko; Janin Reifenrath
Journal:  Diagn Pathol       Date:  2014-11-29       Impact factor: 2.644

4.  Variability in Platelet-Derived Growth Factor Receptor Alpha Antibody Specificity May Impact Clinical Utility of Immunohistochemistry Assays.

Authors:  Timothy R Holzer; Leslie O'Neill Reising; Kelly M Credille; Andrew E Schade; Gerard J Oakley
Journal:  J Histochem Cytochem       Date:  2016-12       Impact factor: 2.479

5.  Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.

Authors:  Qiong Gan; Suzanne Crumley; Russell R Broaddus
Journal:  Int J Gynecol Pathol       Date:  2019-01       Impact factor: 2.762

6.  Comparison of TMA Technique and Routine Whole Slide Analysis in Evaluation of Proliferative Markers Expression in Laryngeal Squamous Cell Cancer.

Authors:  Urszula Ciesielska; Aleksandra Piotrowska; Christopher Kobierzycki; Wojciech Pastuszewski; Marzenna Podhorska-Okolow; Piotr Dziegiel; Katarzyna Nowinska
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

7.  Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study.

Authors:  Tülay Canda; Ekrem Yavuz; Necmettin Özdemir; Sennur İlvan; Serpil Sak Dizbay; Merih Güray Durak; Sıtkı Tuzlalı; Osman Zekioğlu; Atakan Demir; Handan Onur; Kasım Üstündağ; Burçe Göktaş
Journal:  Eur J Breast Health       Date:  2018-07-01

8.  The Long and Winding Road for Breast Cancer Biomarkers to Reach Clinical Utility.

Authors:  Natasha B Hunter; Mark R Kilgore; Nancy E Davidson
Journal:  Clin Cancer Res       Date:  2020-08-28       Impact factor: 12.531

9.  Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia.

Authors:  Duo You; Danfeng Du; Xueke Zhao; Xinmin Li; Minfeng Ying; Xun Hu
Journal:  Chin J Cancer Res       Date:  2021-06-30       Impact factor: 5.087

10.  HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.

Authors:  Belinda J Petri; Kellianne M Piell; Gordon C South Whitt; Ali E Wilt; Claire C Poulton; Norman L Lehman; Brian F Clem; Matthew A Nystoriak; Marcin Wysoczynski; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2021-07-14       Impact factor: 9.756
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.